跳至主要内容
临床试验/NCT06643520
NCT06643520已完成不适用

Sample Adequacy and Diagnostic Accuracy of a 22 Gauge FNB Needle vs a 19G FNB Needle for EUS-guided Liver Biopsy: a Prospective Trial

Duzce University2 个研究点 分布在 1 个国家目标入组 82 人开始时间: 2024年7月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
82
试验地点
2
主要终点
Sample adequacy

研究概览

简要总结

EUS-guided liver biopsy (EUS-LB) is increasingly used to diagnose patients with liver disease, especially in anxious patients who need sedation. There is an ongoing debate about the optimal needle size for EUS-LB. Some clinicians prefer a thinner 22-gauge biopsy needle because they presume it to be safer, and some studies show that their performance is the same as a thicker 19-gauge needle. However, some other studies show that the adequacy and diagnostic accuracy of a 19-gauge needle is better, and the rates of adverse events are the same. In this study, we aimed to compare the adequacy and diagnostic accuracy of samples obtained by the same endoscopist from the same liver lobe during the same session.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Diagnostic
盲法
Triple (Participant, Care Provider, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • All patients with unexplained elevation of liver enzymes and suspected hepatic paranchymal disease

排除标准

  • Patients who had malignancy
  • Patients who have decompensated cirrhosis
  • Presence of ascites
  • Patients with coagulopathy (platelets < 50.000 μ/ mL and INR > 1.5)
  • The use of anticoagulant agents
  • Pregnancy
  • Unable to provide written informed consent

结局指标

主要结局

Sample adequacy

时间窗: 1 month

The sample must have at least 11 complete portal tracts and the length of the longest specimen should be at least 15mm

次要结局

  • Adverse events(1 week)

研究者

发起方
Duzce University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Salih Tokmak

Assoc.Prof. of GI

Duzce University

研究点 (2)

Loading locations...

相似试验